Our Expertise

ESG reporting and Enterprise architecture
At Demeter, we’ve conducted deep research into the intersection of ESG Reporting and Enterprise Architecture, delivering crucial insights for organizational success.

Art market pricing evolution and forecasting
At Demeter, we’re committed to uncovering actionable insights that drive informed decision-making. Recently, we had the privilege of conducting research for a prestigious EU governmental organization operating within the cultural domain. Our focus? Analyzing the evolution and forecast of the art market.

Rare disease medication target 10 countries launch sequence
At Demeter, we’re delving into the strategy behind launching medications for rare diseases across multiple countries. Our innovative research incorporates methods like the Single Multiattribute Rating Technique (SMART) to optimize launch sequences.

